187 related articles for article (PubMed ID: 28346810)
1. An Automated Multiplexed Hepatotoxicity and CYP Induction Assay Using HepaRG Cells in 2D and 3D.
Ott LM; Ramachandran K; Stehno-Bittel L
SLAS Discov; 2017 Jun; 22(5):614-625. PubMed ID: 28346810
[TBL] [Abstract][Full Text] [Related]
2. HepaRG culture in tethered spheroids as an in vitro three-dimensional model for drug safety screening.
Wang Z; Luo X; Anene-Nzelu C; Yu Y; Hong X; Singh NH; Xia L; Liu S; Yu H
J Appl Toxicol; 2015 Aug; 35(8):909-17. PubMed ID: 25512232
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Evaluation of Cytochrome P450 3A4 Inhibition and Hepatotoxicity in HepaRG 3-D Spheroids.
Shin DS; Seo H; Yang JY; Joo J; Im SH; Kim SS; Kim SK; Bae MA
Int J Toxicol; 2018; 37(5):393-403. PubMed ID: 29923436
[TBL] [Abstract][Full Text] [Related]
4. 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies.
Gunness P; Mueller D; Shevchenko V; Heinzle E; Ingelman-Sundberg M; Noor F
Toxicol Sci; 2013 May; 133(1):67-78. PubMed ID: 23377618
[TBL] [Abstract][Full Text] [Related]
5. HepaRG microencapsulated spheroids in DMSO-free culture: novel culturing approaches for enhanced xenobiotic and biosynthetic metabolism.
Rebelo SP; Costa R; Estrada M; Shevchenko V; Brito C; Alves PM
Arch Toxicol; 2015 Aug; 89(8):1347-58. PubMed ID: 25107451
[TBL] [Abstract][Full Text] [Related]
6. A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction.
Sun B; Liang Z; Wang Y; Yu Y; Zhou X; Geng X; Li B
Toxicology; 2024 Jun; 505():153829. PubMed ID: 38740170
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 induction response in tethered spheroids as a three-dimensional human hepatocyte in vitro model.
Xia L; Hong X; Sakban RB; Qu Y; Singh NH; McMillian M; Dallas S; Silva J; Sensenhauser C; Zhao S; Lim HK; Yu H
J Appl Toxicol; 2016 Feb; 36(2):320-9. PubMed ID: 26201057
[TBL] [Abstract][Full Text] [Related]
8. 3D spheroid cultures improve the metabolic gene expression profiles of HepaRG cells.
Takahashi Y; Hori Y; Yamamoto T; Urashima T; Ohara Y; Tanaka H
Biosci Rep; 2015 May; 35(3):. PubMed ID: 26182370
[TBL] [Abstract][Full Text] [Related]
9. Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid.
Foster AJ; Chouhan B; Regan SL; Rollison H; Amberntsson S; Andersson LC; Srivastava A; Darnell M; Cairns J; Lazic SE; Jang KJ; Petropolis DB; Kodella K; Rubins JE; Williams D; Hamilton GA; Ewart L; Morgan P
Arch Toxicol; 2019 Apr; 93(4):1021-1037. PubMed ID: 30915487
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional HepaRG spheroids as a liver model to study human genotoxicity in vitro with the single cell gel electrophoresis assay.
Mandon M; Huet S; Dubreil E; Fessard V; Le Hégarat L
Sci Rep; 2019 Jul; 9(1):10548. PubMed ID: 31332230
[TBL] [Abstract][Full Text] [Related]
11. Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human Hepatocytes.
Hendriks DFG; Vorrink SU; Smutny T; Sim SC; Nordling Å; Ullah S; Kumondai M; Jones BC; Johansson I; Andersson TB; Lauschke VM; Ingelman-Sundberg M
Clin Pharmacol Ther; 2020 Oct; 108(4):844-855. PubMed ID: 32320483
[TBL] [Abstract][Full Text] [Related]
12. From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening.
Ramaiahgari SC; Waidyanatha S; Dixon D; DeVito MJ; Paules RS; Ferguson SS
Toxicol Sci; 2017 Sep; 159(1):124-136. PubMed ID: 28633424
[TBL] [Abstract][Full Text] [Related]
13. Human HepaRG Cells can be Cultured in Hanging-drop Plates for Cytochrome P450 Induction and Function Assays.
Murayama N; Usui T; Slawny N; Chesné C; Yamazaki H
Drug Metab Lett; 2015; 9(1):3-7. PubMed ID: 25600204
[TBL] [Abstract][Full Text] [Related]
14. New Screening Criteria Setting on Evaluation of Cytochrome P450 Induction Using HepaRG Cells with Multiplex Branched DNA Technologies in Early Drug Discovery.
Ogasawara A; Torimoto N; Tsuda N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
Drug Metab Lett; 2016; 10(3):152-160. PubMed ID: 27550199
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study.
Bell CC; Dankers ACA; Lauschke VM; Sison-Young R; Jenkins R; Rowe C; Goldring CE; Park K; Regan SL; Walker T; Schofield C; Baze A; Foster AJ; Williams DP; van de Ven AWM; Jacobs F; Houdt JV; Lähteenmäki T; Snoeys J; Juhila S; Richert L; Ingelman-Sundberg M
Toxicol Sci; 2018 Apr; 162(2):655-666. PubMed ID: 29329425
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an in vitro three-dimensional HepaRG spheroid model for genotoxicity testing using the high-throughput CometChip platform.
Seo JE; He X; Muskhelishvili L; Malhi P; Mei N; Manjanatha M; Bryant M; Zhou T; Robison T; Guo X
ALTEX; 2022; 39(4):583-604. PubMed ID: 35791290
[TBL] [Abstract][Full Text] [Related]
17. A two-dimensional multiwell cell culture method for the production of CYP3A4-expressing hepatocyte-like cells from HepaRG cells.
Ooeda K; Kubiura-Ichimaru M; Tsuji S; Okuyama S; Yamashita M; Mine A; Kawamura F; Ueyama T; Tada M
Pharmacol Res Perspect; 2020 Oct; 8(5):e00652. PubMed ID: 32955797
[TBL] [Abstract][Full Text] [Related]
18. Prediction of cytochrome 450 mediated drug-drug interactions by three-dimensional cultured hepatocytes.
Shen C; Meng Q
Mini Rev Med Chem; 2012 Sep; 12(10):1028-36. PubMed ID: 22512564
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing.
Seo JE; Le Y; Revollo J; Miranda-Colon J; Xu H; McKinzie P; Mei N; Chen T; Heflich RH; Zhou T; Robison T; Bonzo JA; Guo X
Arch Toxicol; 2024 Jun; 98(6):1919-1935. PubMed ID: 38584193
[TBL] [Abstract][Full Text] [Related]
20. Organotypic 3D HepaRG Liver Model for Assessment of Drug-Induced Cholestasis.
Ramaiahgari SC; Ferguson SS
Methods Mol Biol; 2019; 1981():313-323. PubMed ID: 31016663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
